0001179110-22-000696.txt : 20220201
0001179110-22-000696.hdr.sgml : 20220201
20220201212024
ACCESSION NUMBER: 0001179110-22-000696
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220201
DATE AS OF CHANGE: 20220201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carmona Jose
CENTRAL INDEX KEY: 0001693612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 22581315
MAIL ADDRESS:
STREET 1: C/O INNOCOLL HOLDINGS PLC
STREET 2: 3803 WEST CHESTER PIKE
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2022-01-31
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001693612
Carmona Jose
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY ST., SUITE 300
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
6.75
2022-01-31
4
A
0
143750
0
A
2032-01-30
Common Stock
143750
143750
D
Restricted Stock Units
2022-01-31
4
A
0
34500
0
A
Common Stock
34500
34500
D
25% of this option shall vest on January 31, 2023, then in 12 equal quarterly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The shares underlying the restricted stock units vest in four equal annual installments beginning on January 31, 2023.
/s/ Joanne M. Protano, Attorney-in-Fact
2022-02-01